Provision of no-cost, long-acting contraception and teenage pregnancy
about
Hormonal and intrauterine methods for contraception for women aged 25 years and youngerDecreasing Unintended Pregnancy: Opportunities Created by the Affordable Care ActLevonorgestrel-releasing intrauterine systems for long-acting contraception: current perspectives, safety, and patient counselingContraceptive sales in the setting of the Zika virus epidemicReducing Unintended Pregnancies as a Strategy to Avert Zika-Related Microcephaly Births in the United States: A Simulation StudyA Qualitative Study of Factors That Influence Contraceptive Choice among Adolescent School-Based Health Center Patients.Regulatory approval time for hormonal contraception in Canada, the United States and the United Kingdom, 2000-2015: a retrospective data analysis.Understanding the Decline in Adolescent Fertility in the United States, 2007-2012The contraceptive CHOICE project round up: what we did and what we learnedUse of the etonogestrel implant and levonorgestrel intrauterine device beyond the U.S. Food and Drug Administration-approved duration.Contraceptive practices and pregnancy intendedness among pregnant adolescents.Preventing Unintended Pregnancy: The Contraceptive CHOICE Project in ReviewCounseling Adolescents About the Intrauterine Contraceptive Device: A Comparison of Primary Care Pediatricians With Family Physicians and Obstetrician-Gynecologists in the Bronx, New YorkUnderstanding the low uptake of long-acting reversible contraception by young women in Australia: a qualitative study.The levonorgestrel-releasing intrauterine system is associated with delayed endocervical clearance of Chlamydia trachomatis without alterations in vaginal microbiota.Progestins Upregulate FKBP51 Expression in Human Endometrial Stromal Cells to Induce Functional Progesterone and Glucocorticoid Withdrawal: Implications for Contraceptive- Associated Abnormal Uterine Bleeding.Prescription contraception use: a cross-sectional population study of psychosocial determinantsImproving the Implementation of Evidence-Based Clinical Practices in Adolescent Reproductive Health Care Services.Long-term utilization and continuation of intrauterine devices.Pregnancy Outcomes in Youth With Type 2 Diabetes: The TODAY Study ExperienceHormonal contraceptive use in Ireland: trends and co-prescribing practicesMale hormonal contraception: looking back and moving forwardChanges in out-of-pocket costs for hormonal IUDs after implementation of the Affordable Care Act: an analysis of insurance benefit inquiries.Urban Adolescents' and Young Adults' Decision-Making Process around Selection of Intrauterine Contraception.Permanent Sterilisation to Long-Acting Reversible Contraception: Is a Paradigm Shift Necessary?Eliminating health disparities in unintended pregnancy with long-acting reversible contraception (LARC).The role of decidual cells in uterine hemostasis, menstruation, inflammation, adverse pregnancy outcomes and abnormal uterine bleeding.Shared Decision Aids: Increasing Patient Acceptance of Long-Acting Reversible Contraception.The US Supreme Court and the Future of Reproductive HealthContraception for Adolescents: Focusing on Long-Acting Reversible Contraceptives (LARC) to Improve Reproductive Health OutcomesThree-year continuation of reversible contraception.From research to practice: dissemination of the Contraceptive CHOICE Project.Availability of Long-Acting Reversible Contraception in Kansas Health Departments.Bleeding patterns of HIV-infected women using an etonogestrel-releasing contraceptive implant and efavirenz-based or lopinavir/ritonavir-based antiretroviral therapy.Incidence of Discontinuation of Long-Acting Reversible Contraception among Adolescent and Young Adult Women Served by an Urban Primary Care Clinic.Current barriers and potential strategies to increase the use of long-acting reversible contraception (LARC) to reduce the rate of unintended pregnancies in Australia: An expert roundtable discussion.Empowering adolescent girls in Sub-Saharan Africa to prevent unintended pregnancy and HIV: A critical research gap.Contraceptive behaviour of Christian and Muslim teenagers at the time of abortion and post-abortion in Thrace, Greece.Interdependent Barriers to Providing Adolescents with Long-Acting Reversible Contraception: Qualitative Insights from Providers.Let's talk about sex (again): advancing the conversation around long-acting reversible contraception for teenagers.
P2860
Q24187851-9D53BB61-B8F4-4A46-AE8A-5DB1C4C4C754Q26699995-17545C98-C977-4B72-91B1-080AAB18F46CQ28079832-72924F71-883D-4180-B1C1-48D8ABF67BFBQ28119739-26D14135-64FE-4672-B5F1-E590E19052B4Q28583338-1499E317-8696-4A06-A5B3-9FC2EA6031F1Q30781200-8EF3E588-8DD5-46C4-90C6-E572BFF3935BQ31151315-458E8291-5CEE-4992-A24C-1AE09E3D9C0AQ33873966-94B592CE-9289-416A-B37A-AD584ED66607Q34437661-E10DEDAF-F5D3-4098-AE8C-0404BFEE9B44Q35142030-24F339B6-9ABE-424C-B7F6-10B28BA1F90EQ35219751-C3DC794E-4D85-4282-B33F-F0AB1DE13024Q35635318-E6FC1295-0BA5-4636-8B85-04F700943B67Q35738612-2C325494-2124-498F-8844-F3B9D801EB2EQ35770248-F471AFFD-A1F8-44BC-BEA0-1A9F614C0DF3Q35775563-946D80D1-6953-49B4-9BFA-2D7D1E92D74DQ35799214-E02BB5A4-A0CA-4633-B4A4-016A2A699C2AQ35959914-3FE0A3BB-492E-467B-A3F6-1D1816802BB7Q36218237-C49673B6-6716-46C0-9C87-53E0E064FDD6Q36373339-EECE04EC-A05B-4C78-BC0A-72A32DCF4A31Q36392579-C2036DDF-940A-405D-942D-D74448A0CEC9Q36410075-EE79818B-F2F8-4F05-8E89-BE95B8AAE867Q36479889-0884309C-51E4-48CB-B546-077348CCDCA5Q36659191-BFAC4815-DF48-4795-88AD-D6A24C69C95BQ36669748-149D074D-3096-47A9-988A-CB9E33D309D5Q36910932-F453D992-4C2C-4C16-9D0D-E6BEB4681413Q36945498-7C17E3C8-D9D7-415E-A36A-42E63CD64617Q37030520-B9FA5EB8-8F35-4F36-AA9B-4317F9757122Q37081556-5BDF24E7-E120-4F4C-9957-93120BA179F4Q37087859-552052D4-B5EC-4E9E-8E11-58D1A4289AF0Q37252765-52DBD0F6-A22A-45B6-A741-535278C20648Q37624835-54A389D2-3BB6-43BC-B9C2-1B95A50D68ACQ37702978-AFFF5734-DCF7-421D-9E86-75E35F74359BQ38371497-46F47508-DA74-481B-B231-F3F83C8B98E3Q38407716-D1B510A6-4082-4379-95FD-2C800BD88112Q38899003-FC19D0B6-024E-4DA6-94C5-7DEF6335E58EQ38907634-6649248F-3811-4A73-AC8F-7D25DE9D8F7CQ38937910-BDF19880-6B36-4A90-AABC-8E567C08545EQ39381706-200DCA36-FADB-43FF-866A-80C5E863189AQ40018228-0425FD49-66D7-4654-A136-5373D58E8BD6Q40253354-7986D783-E3B4-4F89-852B-9BDEE7EAD5A9
P2860
Provision of no-cost, long-acting contraception and teenage pregnancy
description
2014 nî lūn-bûn
@nan
2014 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Provision of no-cost, long-acting contraception and teenage pregnancy
@ast
Provision of no-cost, long-acting contraception and teenage pregnancy
@en
Provision of no-cost, long-acting contraception and teenage pregnancy
@nl
type
label
Provision of no-cost, long-acting contraception and teenage pregnancy
@ast
Provision of no-cost, long-acting contraception and teenage pregnancy
@en
Provision of no-cost, long-acting contraception and teenage pregnancy
@nl
prefLabel
Provision of no-cost, long-acting contraception and teenage pregnancy
@ast
Provision of no-cost, long-acting contraception and teenage pregnancy
@en
Provision of no-cost, long-acting contraception and teenage pregnancy
@nl
P2093
P2860
P356
P1476
Provision of no-cost, long-acting contraception and teenage pregnancy
@en
P2093
Christina M Buckel
Colleen McNicholas
Gina M Secura
Jeffrey F Peipert
Jennifer Mullersman
Qiuhong Zhao
Tessa Madden
P2860
P304
P356
10.1056/NEJMOA1400506
P407
P577
2014-10-01T00:00:00Z